$EGAN
eGain Corp

2024 Q4 Form 10-Q Financial Statement

#000155837024015305 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $21.80M
YoY Change -9.83%
Cost Of Revenue $6.666M
YoY Change -2.52%
Gross Profit $15.13M
YoY Change -12.72%
Gross Profit Margin 69.42%
Selling, General & Admin $7.203M
YoY Change -22.47%
% of Gross Profit 47.6%
Research & Development $7.421M
YoY Change 11.9%
% of Gross Profit 49.04%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $14.62M
YoY Change -8.15%
Operating Profit $509.0K
YoY Change -64.05%
Interest Expense $771.0K
YoY Change -18.76%
% of Operating Profit 151.47%
Other Income/Expense, Net -$140.0K
YoY Change -122.95%
Pretax Income $1.140M
YoY Change -61.68%
Income Tax $488.0K
% Of Pretax Income 42.81%
Net Earnings $652.0K
YoY Change -74.88%
Net Earnings / Revenue 2.99%
Basic Earnings Per Share $0.02
Diluted Earnings Per Share $0.02
COMMON SHARES
Basic Shares Outstanding 28.52M 28.51M
Diluted Shares Outstanding 29.29M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $67.21M
Short-Term Investments
Other Short-Term Assets $857.0K
YoY Change -34.28%
Inventory
Prepaid Expenses $2.331M
Receivables $23.05M
Other Receivables
Total Short-Term Assets $94.72M
YoY Change -8.36%
LONG-TERM ASSETS
Property, Plant & Equipment $461.0K
YoY Change -16.33%
Goodwill $13.19M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.247M
YoY Change -12.61%
Total Long-Term Assets $20.20M
YoY Change 3.06%
TOTAL ASSETS
Total Short-Term Assets $94.72M
Total Long-Term Assets $20.20M
Total Assets $114.9M
YoY Change -6.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.906M
YoY Change 123.45%
Accrued Expenses $2.513M
YoY Change -42.96%
Deferred Revenue $41.03M
YoY Change -2.21%
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $52.91M
YoY Change -1.73%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities $938.0K
YoY Change 12.61%
Total Long-Term Liabilities $938.0K
YoY Change 12.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $52.91M
Total Long-Term Liabilities $938.0K
Total Liabilities $59.17M
YoY Change 0.8%
SHAREHOLDERS EQUITY
Retained Earnings -$323.0M
YoY Change -1.77%
Common Stock $408.2M
YoY Change 1.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $55.75M
YoY Change
Total Liabilities & Shareholders Equity $114.9M
YoY Change -6.54%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $652.0K
YoY Change -74.88%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $954.0K
YoY Change -88.27%
INVESTING ACTIVITIES
Capital Expenditures $109.0K
YoY Change 240.63%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$109.0K
YoY Change 240.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.422M
YoY Change 821.25%
NET CHANGE
Cash From Operating Activities 954.0K
Cash From Investing Activities -109.0K
Cash From Financing Activities -4.422M
Net Change In Cash -2.798M
YoY Change -142.23%
FREE CASH FLOW
Cash From Operating Activities $954.0K
Capital Expenditures $109.0K
Free Cash Flow $845.0K
YoY Change -89.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2024Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001066194
CY2024Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2024Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
CY2024Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q3 dei Amendment Flag
AmendmentFlag
false
CY2024Q3 dei Document Type
DocumentType
10-Q
CY2024Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q3 dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
CY2024Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q3 dei Entity File Number
EntityFileNumber
001-35314
CY2024Q3 dei Entity Registrant Name
EntityRegistrantName
eGain Corporation
CY2024Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0466366
CY2024Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
1252 Borregas Avenue
CY2024Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Sunnyvale
CY2024Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2024Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94089
CY2024Q3 dei City Area Code
CityAreaCode
408
CY2024Q3 dei Local Phone Number
LocalPhoneNumber
636-4500
CY2024Q3 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2024Q3 dei Trading Symbol
TradingSymbol
EGAN
CY2024Q3 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q3 dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28523870
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
67205000
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
70003000
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
8000
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
8000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
125000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
59000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
23045000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
31731000
CY2024Q3 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
1276000
CY2024Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
1272000
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2331000
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2915000
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
857000
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1195000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
94722000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
107124000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
461000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
441000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3621000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3811000
CY2024Q3 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
1684000
CY2024Q2 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
1779000
CY2024Q3 us-gaap Goodwill
Goodwill
13186000
CY2024Q2 us-gaap Goodwill
Goodwill
13186000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1247000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1511000
CY2024Q3 us-gaap Assets
Assets
114921000
CY2024Q2 us-gaap Assets
Assets
127852000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1906000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2725000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6280000
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7642000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2513000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5078000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1173000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1179000
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
41033000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
45989000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
52905000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
62613000
CY2024Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2875000
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3280000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2455000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2592000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
938000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
871000
CY2024Q3 us-gaap Liabilities
Liabilities
59173000
CY2024Q2 us-gaap Liabilities
Liabilities
69356000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32730000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32698000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28522000
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29160000
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
33000
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
33000
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
408211000
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
407416000
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
4208000
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3538000
CY2024Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
27616000
CY2024Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
23031000
CY2024Q3 egan Notes Receivable From Stockholders
NotesReceivableFromStockholders
21000
CY2024Q2 egan Notes Receivable From Stockholders
NotesReceivableFromStockholders
21000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1850000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2240000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-323009000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-323661000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
55748000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
58496000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
114921000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
127852000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21799000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24176000
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6666000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6838000
CY2024Q3 us-gaap Gross Profit
GrossProfit
15133000
CY2023Q3 us-gaap Gross Profit
GrossProfit
17338000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7421000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6632000
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4760000
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6104000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2443000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3186000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
14624000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
15922000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
509000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1416000
CY2024Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
771000
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
949000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-140000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
610000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1140000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2975000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
488000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
379000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
652000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
2596000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28671000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31479000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29292000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32136000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
652000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
2596000
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
390000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-755000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1042000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1841000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
58496000
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
163000
CY2024Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4585000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
632000
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
390000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
652000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
55748000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
61696000
CY2023Q3 us-gaap Repayments Of Debt
RepaymentsOfDebt
33000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4000
CY2023Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
517000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1208000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-755000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
2596000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
64265000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
652000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
2596000
CY2024Q3 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
354000
CY2023Q3 us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
500000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
274000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
294000
CY2024Q3 egan Depreciation And Amortization Of Capital Lease Assets
DepreciationAndAmortizationOfCapitalLeaseAssets
93000
CY2023Q3 egan Depreciation And Amortization Of Capital Lease Assets
DepreciationAndAmortizationOfCapitalLeaseAssets
107000
CY2024Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
71000
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-110000
CY2024Q3 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-219000
CY2023Q3 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
45000
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
632000
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1208000
CY2024Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8938000
CY2023Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-13100000
CY2024Q3 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
189000
CY2023Q3 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
89000
CY2024Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-597000
CY2023Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
131000
CY2024Q3 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-343000
CY2023Q3 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
44000
CY2024Q3 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-43000
CY2023Q3 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
31000
CY2024Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-830000
CY2023Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1182000
CY2024Q3 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1439000
CY2023Q3 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1706000
CY2024Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2657000
CY2023Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-944000
CY2024Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-5964000
CY2023Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-5124000
CY2024Q3 egan Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-230000
CY2023Q3 egan Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-284000
CY2024Q3 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
47000
CY2023Q3 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
16000
CY2024Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
954000
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8131000
CY2024Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
109000
CY2023Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
32000
CY2024Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-109000
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-32000
CY2024Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
163000
CY2023Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4000
CY2024Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4585000
CY2023Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
517000
CY2023Q3 egan Proceeds From Repayment Of Notes Receivable Due From Stockholders
ProceedsFromRepaymentOfNotesReceivableDueFromStockholders
33000
CY2024Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4422000
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-480000
CY2024Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
779000
CY2023Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-993000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2798000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6626000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
70011000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
73208000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
67213000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
79834000
CY2024Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
586000
CY2023Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
863000
CY2023Q3 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
18000
CY2024Q3 us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Organization and Nature of Business</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">eGain Corporation (eGain, the Company, our, we or us) automates customer engagement with an AI knowledge hub SaaS solution. We sell to enterprises who want to better serve customers at scale by delivering trusted answers across self-service, contact centers, and field staff. True to our mantra of <b style="font-weight:bold;">AX + BX + CX = DX™</b>, our AI knowledge hub orchestrates effortless Digital eXperience (DX) as it assists Agent eXperience (AX), empowers Business eXperience (BX) and assures Customer eXperience (CX). Many global brands use eGain to improve experience and reduce costs. We are headquartered in the Sunnyvale, California, United States. We also operate in the United Kingdom and India.</p>
CY2024Q3 us-gaap Fiscal Period
FiscalPeriod
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Fiscal Year</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><span style="font-size:10pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The Company fiscal year ends on June 30. References to fiscal year 2025 refers to the Company’s fiscal year ending June 30, 2025. References to fiscal year 2024 refers to the Company’s fiscal year ending June 30, 2024.</p>
CY2024Q3 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Use of Estimates</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The preparation of financial statements requires us to make estimates and assumptions in the condensed consolidated financial statements and accompanying notes. Actual results could differ significantly from estimates. We make estimates </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">that we believe to be reasonable based on historical experience and other assumptions. Significant estimates and assumptions made by management include the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Standalone selling price (SSP) of performance obligations for contracts with multiple performance obligations;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Estimate of variable consideration for performance obligations in connection with Topic 606;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Period of benefit associated with capitalized costs to obtain revenue contracts;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Valuation, measurement and recognition of current and deferred income taxes;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Fair value of stock-based awards; and </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Lease term and incremental borrowing rate for lease liabilities.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p>
CY2023Q3 egan Number Of Revenue Categories
NumberOfRevenueCategories
2
CY2024Q3 egan Number Of Revenue Categories
NumberOfRevenueCategories
2
CY2024Q3 egan Revenue Payment Term Minimum
RevenuePaymentTermMinimum
P30D
CY2024Q3 egan Revenue Payment Term Maximum
RevenuePaymentTermMaximum
P45D
CY2024Q3 egan Contract Cost Capitalized During Period
ContractCostCapitalizedDuringPeriod
189000
CY2023Q3 egan Contract Cost Capitalized During Period
ContractCostCapitalizedDuringPeriod
89000
CY2024Q3 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
354000
CY2023Q3 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
500000
CY2024Q3 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
3000000.0
CY2024Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
3100000
CY2023Q3 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2024Q3 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q3 egan Number Of Operating Regions
NumberOfOperatingRegions
3
CY2024Q3 egan Number Of Operating Regions
NumberOfOperatingRegions
3
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
509000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1416000
CY2024Q3 us-gaap Noncurrent Assets
NoncurrentAssets
461000
CY2024Q2 us-gaap Noncurrent Assets
NoncurrentAssets
441000
CY2024Q3 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Concentration of Credit Risk and Significant Customers </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Our financial instruments that are exposed to concentrations of credit risk include cash and cash equivalents, restricted cash, and accounts receivable. <span style="background:#ffffff;">We complement direct sales with resell partnerships based on product connectors into cloud contact center platforms. We also partner with system integrators and managed service providers.</span> Two customers, including one of our partners, accounted for 15% and 10%, respectively, of total revenue during the three months ended September 30, 2024. The same customers and including one of our partner accounted for 17% and 11% of total revenue during the three months ended September 30, 2023. Three and two customers accounted for more than 10% of our gross accounts receivable, less provision for credit losses balance as of September 30, 2024 and 2023, respectively.</p>
CY2024Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
1500000
CY2024Q2 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
3600000
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
632000
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1208000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21799000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24176000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21799000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24176000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21799000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24176000
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
41033000
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
45989000
CY2024Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2875000
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3280000
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
43908000
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
49269000
CY2024Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
12100000
CY2024Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
70400000
CY2024Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
54500000
CY2024Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
15900000
CY2024Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
652000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
2596000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28671000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31479000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29292000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32136000
CY2024 egan Number Of Operating Leases Modified
NumberOfOperatingLeasesModified
3
CY2024 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2100000
CY2024Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
300000
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
326000
CY2024Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
274000
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
315000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3621000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3811000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1173000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1179000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2455000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2592000
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y3M29D
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y6M7D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0777
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0766
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
886000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1068000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
822000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
295000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
295000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
295000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
1031000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4692000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1064000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
3628000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1173000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2455000
CY2024Q3 egan Warranty Period Maximum
WarrantyPeriodMaximum
P1Y
CY2024Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
12400000
CY2022Q4 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P1Y
CY2024Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
670824
CY2024Q3 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
6.84
CY2024Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4600000
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001558370-24-015305-index-headers.html Edgar Link pending
0001558370-24-015305-index.html Edgar Link pending
0001558370-24-015305.txt Edgar Link pending
0001558370-24-015305-xbrl.zip Edgar Link pending
egan-20240930.xsd Edgar Link pending
egan-20240930x10q.htm Edgar Link pending
egan-20240930xex31d1.htm Edgar Link pending
egan-20240930xex31d2.htm Edgar Link pending
egan-20240930xex32d1.htm Edgar Link pending
egan-20240930x10q_htm.xml Edgar Link completed
egan-20240930xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
egan-20240930_def.xml Edgar Link unprocessable
egan-20240930_lab.xml Edgar Link unprocessable
egan-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
egan-20240930_cal.xml Edgar Link unprocessable